GLAM
FOLD

Gardner Lewis Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Gardner Lewis Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,414,748
Closed -$20.5M – 91
2026
Q1 		$20.5M Buy
+1,414,748
New +$20.3M 4.43% 2

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Gardner Lewis Asset Management's FOLD Position: Q2 2026 in Review

Gardner Lewis Asset Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 1,414,748 shares — an estimated $20.5M sold.

Gardner Lewis Asset Management first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $20.5M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Gardner Lewis Asset Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 1,414,748 Amicus Therapeutics shares in Q2 2026, an estimated $20.5M.
  • Gardner Lewis Asset Management first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
  • Gardner Lewis Asset Management's Amicus Therapeutics position peaked at $20.5M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Gardner Lewis Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.